retatrutide news today recency 3 🚨Breaking: Retatrutide's first Phase T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide Phase 2 vs Phase

The primary published evidence base includes the Phase 2 randomised controlled trial reported by Jastreboff et al

Springer Healthcare

So thats interesting

Possible Side Effects Like other incretin-based therapies, Retatrutide may cause some side effects

Rivas telehealth is backed by a real clinical organization 15 physical clinics, hundreds of patients seen every week, and providers who specialize in weight loss and nothing else

This transition will be driven by accumulating health economic evidence demonstrating cost-effectiveness through reduced cardiovascular events and progression of metabolic disease, leading to structured public reimbursement programs in Europe, Japan, and middle-income countries